Related Experiment Videos
Involvement of Mac-1 antigen in tumor cell killing by macrophages
1Department of Immunology, Tohoku University, Sendai.
The Tohoku Journal of Experimental Medicine
|June 1, 1988
Abstract:
Some tumor cells such as YAC-1 and RL male 1 were killed by mouse peritoneal macrophages elicited with OK-432 one day before the harvest. The killing reactions were inhibited specifically by anti-Mac-1. The results suggest that some macrophages generated early after the injection of OK-432 kill tumor cells with the aid of CR3.
Insights
OK-432 treatment enhances mouse macrophages to kill tumor cells. This tumor cell killing is mediated by Mac-1 and complement receptor 3 (CR3) on macrophages.
Area of Science:
- Immunology
- Cell Biology
Background:
- OK-432 is an immunomodulator used to stimulate immune responses.
- Macrophages play a critical role in tumor surveillance and elimination.
Purpose of the Study:
- To investigate the role of macrophages elicited by OK-432 in tumor cell killing.
- To identify the specific molecular mechanisms involved in this cytotoxic activity.
Main Methods:
- Peritoneal macrophages were harvested from mice treated with OK-432.
- Tumor cells (YAC-1 and RL male 1) were co-cultured with these macrophages.
- The cytotoxic effect was assessed, and the role of Mac-1 was investigated using anti-Mac-1 antibodies.
Main Results:
- OK-432-elicited macrophages demonstrated cytotoxic activity against YAC-1 and RL male 1 tumor cells.
- The tumor cell killing was specifically inhibited by anti-Mac-1 antibodies.
- This suggests the involvement of Mac-1 and potentially complement receptor 3 (CR3) in the observed cytotoxicity.
Conclusions:
- Early-stage macrophages induced by OK-432 possess the ability to kill certain tumor cells.
- The Mac-1 molecule and CR3 are implicated as key mediators in this OK-432-induced anti-tumor immune response.